Exane Derivatives’s Pfizer PFE Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$709K	Sell	13,531 -7,785	-37%	-$408K	0.41%	56
2022 Q1	$1.1M	Sell	21,316 -819	-4%	-$42.4K	0.31%	77
2021 Q4	$1.31M	Buy	22,135 +2,361	+12%	+$139K	0.32%	63
2021 Q3	$850K	Sell	19,774 -11,435	-37%	-$492K	0.2%	102
2021 Q2	$1.24M	Sell	31,209 -11,701	-27%	-$464K	0.28%	77
2021 Q1	$1.55M	Buy	42,910 +14,132	+49%	+$512K	0.44%	43
2020 Q4	$1.06M	Buy	28,778 +19,756	+219%	+$709K	0.31%	77
2020 Q3	$331K	Sell	9,022 -1,018	-10%	-$37.4K	0.1%	156
2020 Q2	$328K	Sell	10,040 -2,916	-23%	-$95.4K	0.09%	171
2020 Q1	$423K	Sell	12,956 -1,368	-10%	-$44.6K	0.12%	123
2019 Q4	$582K	Sell	14,324 -4,128	-22%	-$168K	0.11%	147
2019 Q3	$663K	Buy	+18,452	New	+$663K	0.12%	129
2018 Q4	–	Sell	-32,514	Closed	-$1.43M	–	680
2018 Q3	$1.43M	Buy	+32,514	New	+$1.43M	0.27%	80
2018 Q2	–	Sell	-63,004	Closed	-$2.22M	–	660
2018 Q1	$2.22M	Buy	+63,004	New	+$2.22M	0.44%	45
2016 Q1	–	Sell	-20,805	Closed	-$672K	–	547
2015 Q4	$672K	Buy	20,805 +2,248	+12%	+$72.6K	0.09%	89
2015 Q3	$583K	Buy	18,557 +4,040	+28%	+$127K	0.07%	99
2015 Q2	$487K	Buy	14,517 +1,500	+12%	+$50.3K	0.05%	125
2015 Q1	$453K	Sell	13,017 -7,337	-36%	-$255K	0.05%	133
2014 Q4	$634K	Buy	+20,354	New	+$634K	0.09%	108